Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-world Study for the Safety of Albumin-Bound Paclitaxel in Malignant Tumors

NCT04060290 is registered in ClinicalTrials.gov with CSPC ZhongQi Pharmaceutical Technology Co., Ltd. as lead sponsor.

NCT NCT04060290
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04060290 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-world Study for the Safety of Albumin-Bound Paclitaxel in Malignant Tumors
Lead sponsor
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase
Observational
Overall status
Completed
Start date
May 12, 2020
Completion date
February 1, 2024
Enrollment
1,000 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

cancer